Search results for "Determination"

showing 10 items of 718 documents

Minimal clinically important difference for asthma endpoints: an expert consensus report

2020

Minimal clinically important difference (MCID) can be defined as the smallest change or difference in an outcome measure that is perceived as beneficial and would lead to a change in the patient's medical management.The aim of the current expert consensus report is to provide a “state-of-the-art” review of the currently available literature evidence about MCID for end-points to monitor asthma control, in order to facilitate optimal disease management and identify unmet needs in the field to guide future research.A series of MCID cut-offs are currently available in literature and validated among populations of asthmatic patients, with most of the evidence focusing on outcomes as patient repo…

Asthma asthma management minimal clinically important difference end-pointsPulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusDelphi TechniqueEndpoint DeterminationBronchoconstrictionMEDLINEDelphi methodSocio-culturaleSettore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIOminimal clinically important difference; asthma; lung function; biomarkersMCID03 medical and health sciences0302 clinical medicinePredictive Value of TestsmedicineHumansAnti-Asthmatic Agents030212 general & internal medicineDisease management (health)Intensive care medicineLungAsthmalcsh:RC705-779business.industryMinimal clinically important differenceminimal clinically important differenceExpert consensusend-pointslcsh:Diseases of the respiratory systemmedicine.diseaseMCID asthmaAsthmaTreatment Outcome030228 respiratory systemPredictive value of testsEndpoint DeterminationInflammation MediatorsSymptom AssessmentbusinessBiomarkersasthma managementEuropean Respiratory Review
researchProduct

DETERMINATION OF TDC IN INTERNAL COMBUSTION ENGINES BY A NEWLY DEVELOPED THERMODYNAMIC APPROACH

2010

Abstract In-cylinder pressure analysis is nowadays an indispensable tool in internal combustion engine research & development. It allows the measure of some important performance related parameters, such as indicated mean effective pressure (IMEP), mean friction pressure, indicated fuel consumption, heat release rate, mass fraction burned, etc. Moreover, future automotive engine will probably be equipped with in-cylinder pressure sensors for continuous combustion monitoring and control, in order to fulfil the more and more strict emission limits. For these reasons, in-cylinder pressure analysis must be carried out with maximum accuracy, in order to minimize the effects of its characteristic…

Automotive engineCrankEngineeringbusiness.industryEnergy Engineering and Power TechnologyMechanical engineeringPressure sensorIndustrial and Manufacturing Engineeringlaw.inventionPressure measurementDead centreSettore ING-IND/08 - Macchine A FluidoMean effective pressureInternal combustion enginelawinternal combustion enginetop dead centre determinationSpark plugbusiness
researchProduct

p62: Friend or Foe? Evidences for OncoJanus and NeuroJanus Roles

2020

p62 is a versatile protein involved in the delicate balance between cell death and survival, which is fundamental for cell fate decision in the context of both cancer and neurodegenerative diseases. As an autophagy adaptor, p62 recognizes polyubiquitin chains and interacts with LC3, thereby targeting the selected cargo to the autophagosome with consequent autophagic degradation. Beside this function, p62 behaves as an interactive hub in multiple signalling including those mediated by Nrf2, NF-κB, caspase-8, and mTORC1. The protein is thus crucial for the control of oxidative stress, inflammation and cell survival, apoptosis, and metabolic reprogramming, respectively. As a multifunctional pr…

AutophagosomeProgrammed cell deathP62ApoptosisContext (language use)mTORC1Cell fate determinationBiologyCatalysislcsh:ChemistryInorganic ChemistryStress granuleAutophagymedicinePhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyCancerNeurodegenerative diseasesOrganic ChemistryNeurodegenerationAutophagyGeneral Medicinemedicine.diseaseComputer Science ApplicationsCell biologylcsh:Biology (General)lcsh:QD1-999International Journal of Molecular Sciences
researchProduct

Measurement of CP asymmetry in Bs0 → Ds ∓K± decays

2014

Journal of high energy physics 2018(3), 59 (2018). doi:10.1007/JHEP03(2018)059

B physicCKM angle gamma01 natural sciencesB physicsLuminosityFlavor physicsHadron-Hadron scattering (experiments)TOOLLHCb - Abteilung HintonQCmedia_commonPhysicsParticle physicsCharge conjugation parity time reversal and other discrete symmetrie12.15.HhB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron ScatteringJustice and Strong InstitutionsCP violationB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron Scattering; Nuclear and High Energy PhysicsFísica nuclearLHCAstrophysics::Earth and Planetary AstrophysicsParticle physicsNuclear and High Energy PhysicsVIOLATIONSDG 16 - PeaceVIOLATION; GAMMA; TOOLAstrophysics::High Energy Astrophysical Phenomenamedia_common.quotation_subject14.40.NdLHCb - Abteilung HofmannAstrophysics::Cosmology and Extragalactic AstrophysicsHadrons530Determination of Cabibbo-Kobayashi & Maskawa (CKM) matrix elementAsymmetryNOHadronic decays of bottom mesonTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical scienceslcsh:Nuclear and particle physics. Atomic energy. Radioactivityddc:530010306 general physicsLarge Hadron Collider (France and Switzerland)Astrophysics::Galaxy AstrophysicsHadron-Hadron Scattering010308 nuclear & particles physicsSDG 16 - Peace Justice and Strong InstitutionsGran Col·lisionador d'HadronsGAMMA/dk/atira/pure/sustainabledevelopmentgoals/peace_justice_and_strong_institutionsHEPLHCbFlavor physic13.25.HwB physics; CKM angle gamma; CP violation; Flavor physics; Hadron-Hadron scattering (experiments)lcsh:QC770-798Bottom mesons (|B|>0)11.30.ErHigh Energy Physics::ExperimentB physics CKM angle gamma CP violation Flavor physics Hadron-Hadron ScatteringFísica de partículesExperiments
researchProduct

The efficacy of balneotherapy, mud therapy and spa therapy in patients with osteoarthritis: an overview of reviews.

2021

Osteoarthritis is a degenerative disease considered a leading cause of functional disability. Its treatment is based on a combination of pharmacological and non-pharmacological interventions, but the role of these latter is still debated. This overview of systematic reviews aimed at evaluating the short-term efficacy of different thermal modalities in patients with osteoarthritis. We searched PubMed, Scopus, CINHAL, Web of Science, ProQuest and the Cochrane Database of Systematic Reviews from inception until October 2020, with no language restrictions. We selected the following outcomes a priori: pain, stiffness and quality of life. Seventeen systematic reviews containing 27 unique relevant…

BalneotherapyAtmospheric Sciencemedicine.medical_specialty010504 meteorology & atmospheric sciencesBalneotherapyHealth Toxicology and Mutagenesismedicine.medical_treatmentPopulationPsychological interventionOsteoarthritis01 natural sciences03 medical and health sciences0302 clinical medicineQuality of life (healthcare)systematic reviewnursingOsteoarthritismedicineHumanseducation0105 earth and related environmental sciencesRandomized Controlled Trials as Topic030203 arthritis & rheumatologyeducation.field_of_studyModalitiesEcologybusiness.industryBalneologyMud Therapymedicine.diseasecomplemetary therapieSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSystematic reviewSample size determinationPhysical therapyQuality of LifeMud pack therapyOsteoarthritibusinessSystematic Reviews as TopicInternational journal of biometeorology
researchProduct

2013

Currently, a growing number of programs become available in statistical software for multiple imputation of missing values. Among others, two algorithms are mainly implemented: Expectation Maximization (EM) and Multiple Imputation by Chained Equations (MICE). They have been shown to work well in large samples or when only small proportions of missing data are to be imputed. However, some researchers have begun to impute large proportions of missing data or to apply the method to small samples. A simulation was performed using MICE on datasets with 50, 100 or 200 cases and four or eleven variables. A varying proportion of data (3% - 63%) was set as missing completely at random and subsequent…

Binary responseSample size determinationStatisticsExpectation–maximization algorithmEconometricsMain effectImputation (statistics)Missing dataInteractionLogistic regressionMathematicsOpen Journal of Statistics
researchProduct

Analysis of the structural quality of the CASD-NMR 2013 entries

2015

We performed a comprehensive structure validation of both automated and manually generated structures of the 10 targets of the CASD-NMR-2013 effort. We established that automated structure determination protocols are capable of reliably producing structures of comparable accuracy and quality to those generated by a skilled researcher, at least for small, single domain proteins such as the ten targets tested. The most robust results appear to be obtained when NOESY peak lists are used either as the primary input data or to augment chemical shift data without the need to manually filter such lists. A detailed analysis of the long-range NOE restraints generated by the different programs from t…

BiochimieProteinNMR NOE Protein Structure determination Validation Spectroscopy Biochemistry Structural BiologyBiochemistryQualityArticleNMRBlind testingSpectroscopie [électromagnétisme optique acoustique]CASD-NMRValidationSpectroscopie [état condense]Structure determinationSpectroscopyNOE
researchProduct

Detection of condition-specific marker genes from RNA-seq data with MGFR

2019

The identification of condition-specific genes is key to advancing our understanding of cell fate decisions and disease development. Differential gene expression analysis (DGEA) has been the standard tool for this task. However, the amount of samples that modern transcriptomic technologies allow us to study, makes DGEA a daunting task. On the other hand, experiments with low numbers of replicates lack the statistical power to detect differentially expressed genes. We have previously developed MGFM, a tool for marker gene detection from microarrays, that is particularly useful in the latter case. Here, we have adapted the algorithm behind MGFM to detect markers in RNA-seq data. MGFR groups s…

Bioinformaticslcsh:MedicineRNA-SeqComputational biologyMarker genesCell fate determinationBiologyMarker geneGeneral Biochemistry Genetics and Molecular BiologyTranscriptomeBioconductor03 medical and health sciences0302 clinical medicineGene expressionSingle cellRNA-SeqTranscriptomicsGene030304 developmental biology0303 health sciencesGeneral Neurosciencelcsh:RCell-type specificityGenomicsGeneral MedicineTissue specificity030220 oncology & carcinogenesisGene expressionR-packageDNA microarrayGeneral Agricultural and Biological SciencesPeerJ
researchProduct

Analysis of emerging contaminants and nanomaterials in plant materials following uptake from soils

2017

The reuse of treated wastewater or wastewater-impacted river water is growing, particularly in arid areas, due to the climate change. As well, the disposal of sludges, biosolids or biochar as soil amendments to improve agricultural output is widely implemented in the EU. These practices can be a source of emerging contaminants and engineering nanomaterials (ENMs) to the environment and condition their incorporation to food chain that could affect human beings. This review covers current analytical techniques, instruments and methodologies used to determine emerging contaminants and ENMs from irrigation water and/or soil amendments in plants. Trends regarding sample treatment, separation and…

BiosolidsPlant uptakeExtraction010501 environmental sciencesReuse01 natural sciencesEngineering nanomaterialsAnalytical ChemistrySeparationFood chainAnalytical methodsBiocharDetection of nanoformsDeterminationSpectroscopy0105 earth and related environmental sciencesEmerging contaminantsbusiness.industry010401 analytical chemistryEnvironmental engineering0104 chemical sciencesSoil conditionerWastewaterAgricultureEnvironmental chemistrySoil waterEnvironmental sciencebusiness
researchProduct

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular …

2012

Abstract Background and aims Metformin is the first-line therapy in type 2 diabetes. In patients inadequately controlled with metformin, the addition of a sulfonylurea or pioglitazone are equally plausible options to improve glycemic control. However, these drugs have profound differences in their mechanism of action, side effects, and impact on cardiovascular risk factors. A formal comparison of these two therapies in terms of cardiovascular morbidity and mortality is lacking. The TOSCA.IT study was designed to explore the effects of adding pioglitazone or a sulfonylurea on cardiovascular events in type 2 diabetic patients inadequately controlled with metformin. Methods Multicentre, random…

Blood GlucoseMaleBIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICAEndocrinology Diabetes and Metabolismpioglitazone sulfonylurea type 2 diabetes metformin cardiovascular eventsMedicine (miscellaneous)Type 2 diabetesSettore MED/13 - EndocrinologiaBody Mass Indexlaw.inventionRandomized controlled trialRisk FactorslawSurveys and QuestionnairesCardiovascular DiseasepioglitazonepiogllitazoneStrokeDiabetes Therapy PioglitazoneNutrition and DieteticsDiabetesThiazolidinedionecardiovascular events; pioglitazone; Type 2 Diabetes Mellitus; sulphonylureasType 2 diabetesMiddle AgedMetforminSulfonylurea CompoundTreatment OutcomeTolerabilitysulphonylureasCardiovascular DiseasesDrug Therapy CombinationFemaletype 2 diabetesCardiology and Cardiovascular MedicineHumanmedicine.drugmedicine.medical_specialtyEndpoint Determinationsulfonylureacardiovascualr eventSudden deathFollow-Up Studiecardiovascular eventsInternal medicineDiabetes mellitusmedicineHumansHypoglycemic Agentssulfonylureasinterventio trialtype 2 diabetes; cardiovascular events; pioglitazone; sulfonylureas; randomized controlled trialAgedHypoglycemic AgentQuestionnairebusiness.industryRisk Factormedicine.diseaseSurgeryType 2 Diabetes MellitusSulfonylurea CompoundsDiabetes Mellitus Type 2randomized controlled trialQuality of LifeThiazolidinedionesTherapybusinessmetforminPioglitazoneFollow-Up Studies
researchProduct